Found: 7
Select item for more details and to access through your institution.
Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatment.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11113-y
- By:
- Publication type:
- Article
In-depth Analysis of the Lid Subunits Assembly Mechanism in Mammals.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 6, p. 213, doi. 10.3390/biom9060213
- By:
- Publication type:
- Article
Assembly Mechanisms of Specialized Core Particles of the Proteasome.
- Published in:
- Biomolecules (2218-273X), 2014, v. 4, n. 3, p. 662, doi. 10.3390/biom4030662
- By:
- Publication type:
- Article
Dissecting β-ring assembly pathway of the mammalian 20S proteasome.
- Published in:
- EMBO Journal, 2008, v. 27, n. 16, p. 2204, doi. 10.1038/emboj.2008.148
- By:
- Publication type:
- Article
Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-79051-1
- By:
- Publication type:
- Article
Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY).
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 2, p. 477, doi. 10.1007/s00417-021-05308-8
- By:
- Publication type:
- Article